Press "Enter" to skip to content

New patent for Endo Pharms drug AVEED

3
Copyright © DrugPatentWatch. Originally published at New patent for Endo Pharms drug AVEED

Annual Drug Patent Expirations for AVEED
Annual Drug Patent Expirations for AVEED

Aveed is a drug marketed by Endo Pharms Inc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for AVEED.

This drug has forty-eight patent family members in thirty-eight countries.

The generic ingredient in AVEED is testosterone undecanoate. One supplier is listed for this compound. Additional details are available on the testosterone undecanoate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Endo Pharms drug AVEED

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!